Differential effects of K v11.1 activators on K v11.1a, K v11.1b and K v11.1a/K v11.1b channels

British Journal of Pharmacology

Volumn 161, Issue 3, 2010, Pages 614-628

  Larsen, A P ^a   Bentzen, B H ^a   Grunnet, M ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

hERG1a; hERG1b; Kv11.1a; Kv11.1b; NS1643; RPR260243

Indexed keywords

1,3 BIS (2 HYDROXY 5 TRIFLUOROMETHYLPHENYL)UREA; 4 [3 (6 METHOXYQUINOLIN 4 YL) 3 OXOPROPYL] 1 [3 (2,3,5 TRIFLUOROPHENYL)PROP 2 YNYL]PIPERIDINE 3 CARBOXYLIC ACID; NS 1643; POTASSIUM CHANNEL KV11.1; POTASSIUM CHANNEL KV11.1A; POTASSIUM CHANNEL KV11.1B; POTASSIUM CHANNEL STIMULATING AGENT; RPR 260243; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; 1,3 BIS(2 HYDROXY 5 TRIFLUOROMETHYLPHENYL)UREA; 1,3-BIS(2-HYDROXY-5-TRIFLUOROMETHYLPHENYL)UREA; CARBANILAMIDE DERIVATIVE; CRESOL; ERG1 POTASSIUM CHANNEL; ISOPROTEIN; PIPERIDINE DERIVATIVE; POTASSIUM CHANNEL HERG; QUINOLINE DERIVATIVE; RPR260243;

ANIMAL CELL; ARTICLE; DRUG EFFECT; NONHUMAN; NUCLEOTIDE SEQUENCE; OOCYTE; PRIORITY JOURNAL; VOLTAGE CLAMP; XENOPUS LAEVIS; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG POTENTIATION; GENETIC TRANSFECTION; GENETICS; PATCH CLAMP; PHYSIOLOGY;

ANIMALS; CRESOLS; ETHER-A-GO-GO POTASSIUM CHANNELS; MEMBRANE POTENTIALS; OOCYTES; PATCH-CLAMP TECHNIQUES; PHENYLUREA COMPOUNDS; PIPERIDINES; PROTEIN ISOFORMS; QUINOLINES; TRANSFECTION; XENOPUS LAEVIS;

EID: 77956320475     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00897.x     Document Type: Article

References (27)

1. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Casis O, Olesen SP, Sanguinetti MC (2006). Mechanism of action of a novel human ether-a-go-go-related gene channel activator. Mol Pharmacol 69 : 658 665.
3. + channels: spike-frequency adaptation. J Physiol 501 : 313 318.
4. Diness TG, Yeh YH, Qi XY, Chartier D, Tsuji Y, Hansen RS et al. (2008). Antiarrhythmic properties of a rapid delayed-rectifier current activator in rabbit models of acquired long QT syndrome. Cardiovasc Res 79 : 61 69.
5. Farrelly AM, Ro S, Callaghan BP, Khoyi MA, Fleming N, Horowitz B et al. (2003). Expression and function of KCNH2 (HERG) in the human jejunum. Am J Physiol Gastrointest Liver Physiol 284 : G883 G895.
6. Guasti L, Cilia E, Crociani O, Hofmann G, Polvani S, Becchetti A et al. (2005). Expression pattern of the ether-a-go-go-related (ERG) family proteins in the adult mouse central nervous system: evidence for coassembly of different subunits. J Comp Neurol 491 : 157 174.
7. + channel expression and hERG1 current density in tumor cells. Mol Cell Biol 28 : 5043 5060.
8. Hansen RS, Diness TG, Christ T, Demnitz J, Ravens U, Olesen SP et al. (2006a). Activation of human ether-a-go-go-related gene potassium channels by the diphenylurea 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643). Mol Pharmacol 69 : 266 277.
9. Hansen RS, Diness TG, Christ T, Wettwer E, Ravens U, Olesen SP et al. (2006b). Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N′- (3′-trifluoromethylphenyl)urea]. Mol Pharmacol 70 : 1319 1329.
10. Hansen RS, Olesen SP, Grunnet M (2007). Pharmacological activation of rapid delayed rectifier potassium current suppresses bradycardia-induced triggered activity in the isolated guinea pig heart. J Pharmacol Exp Ther 321 : 996 1002.
11. Huffaker SJ, Chen J, Nicodemus KK, Sambataro F, Yang F, Mattay V et al. (2009). A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia. Nat Med 15 : 509 518.
12. Jespersen T, Grunnet M, Angelo K, Klaerke DA, Olesen SP (2002). Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes. Biotechniques 32 : 536 540.
13. Jones EM, Roti Roti EC, Wang J, Delfosse SA, Robertson GA (2004). Cardiac IKr channels minimally comprise hERG 1a and 1b subunits. J Biol Chem 279 : 44690 44694.
14. + channel. Mol Pharmacol 67 : 827 836.
15. + channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current. J Biol Chem 273 : 27231 27235.
16. Larsen AP, Olesen SP (2010). Differential expression of hERG1 channel isoforms reproduces properties of native I(Kr) and modulates cardiac action potential characteristics. PLoS ONE 5 : e9021.
17. Larsen AP, Olesen SP, Grunnet M, Jespersen T (2008). Characterization of hERG1a and hERG1b potassium channels-a possible role for hERG1b in the I (Kr) current. Pflugers Arch 456 : 1137 1148.
18. + channel in mouse and human hearts. Circ Res 81 : 719 726.
19. + current. Circ Res 81 : 870 878.
20. Ohya S, Horowitz B, Greenwood IA (2002). Functional and molecular identification of ERG channels in murine portal vein myocytes. Am J Physiol Cell Physiol 283 : C866 C877.
21. Perry M, Sachse FB, Sanguinetti MC (2007). Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator. Proc Natl Acad Sci USA 104 : 13827 13832.
22. + conductance. Proc Natl Acad Sci USA 106 : 20075 20080.
23. Sanguinetti MC, Jiang C, Curran ME, Keating MT (1995). A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81 : 299 307.
24. Trudeau MC, Warmke JW, Ganetzky B, Robertson GA (1995). HERG, a human inward rectifier in the voltage-gated potassium channel family. Science 269 : 92 95.
25. Warmke JW, Ganetzky B (1994). A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci USA 91 : 3438 3442.
26. Xu X, Recanatini M, Roberti M, Tseng GN (2008). Probing the binding sites and mechanisms of action of two human ether-a-go-go-related gene channel activators, 1,3-bis-(2-hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243). Mol Pharmacol 73 : 1709 1721.
27. Zhou J, Augelli-Szafran CE, Bradley JA, Chen X, Koci BJ, Volberg WA et al. (2005). Novel potent human ether-a-go-go-related gene (hERG) potassium channel enhancers and their in vitro antiarrhythmic activity. Mol Pharmacol 68 : 876 884.